MMP9 and cancer: Besides, it seems likely that cell-impermeable inhibitors of HSP90 activity are able to downregulate cancer stemness-associated extracellular proteinases, such as MMP2 and MMP9, whose expression, secretion, and activity are dependent on extracellular HSP90 [102].